Cannassure Therapeutics Ltd
CannAssure Ltd cultivates and produces medical cannabis. The company was incorporated in 2017 and is headquartered in Ashdod, Israel.
Cannassure Therapeutics Ltd (CSURE) - Net Assets
Latest net assets as of : ILA- ILA
Based on the latest financial reports, Cannassure Therapeutics Ltd (CSURE) has net assets worth ILA- ILA as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (ILA-) and total liabilities (ILA-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ILA- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Cannassure Therapeutics Ltd - Net Assets Trend (None–None)
This chart illustrates how Cannassure Therapeutics Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Cannassure Therapeutics Ltd (None–None)
The table below shows the annual net assets of Cannassure Therapeutics Ltd from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to Cannassure Therapeutics Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
Cannassure Therapeutics Ltd Competitors by Market Cap
The table below lists competitors of Cannassure Therapeutics Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
CHAMPION BEAR RES
BE:OX9
|
$583.19 |
|
HONG KONG PARKVIEW
BE:HKP
|
$583.43 |
|
Plant Veda Foods Ltd
PINK:PLVFF
|
$584.04 |
|
MAST Energy Developments PLC
LSE:MAST
|
$584.36 |
|
DRJ International Group Limited Inc.
PINK:RGSTD
|
$582.40 |
|
Vallibel Power Erathna PLC
CM:VPELN0000
|
$582.23 |
|
GUANGZHOU R&F P-H-
MU:G5HA
|
$582.06 |
|
Energy Finders Inc
PINK:EGYF
|
$580.80 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Cannassure Therapeutics Ltd's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares Cannassure Therapeutics Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Cannassure Therapeutics Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares Cannassure Therapeutics Ltd's net assets metrics with peer companies in the Healthcare Providers & Services industry.
No peer company data available for comparison.